Stabilization of human RNA and DNA in stool samples at room temperature

This study examines the stability of human mRNA and DNA in stool samples for noninvasive gastrointestinal disease detection. While stool samples are valuable for diagnosing conditions like inflammatory disorders and colorectal cancer, mRNA instability poses significant challenges, risking false-nega...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:BioTechniques. - 1991. - (2025) vom: 18. Aug., Seite 1-9
1. Verfasser: Preywisch, Regina (VerfasserIn)
Weitere Verfasser: Løvlie, Roger, Eidens, Moritz
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2025
Zugriff auf das übergeordnete Werk:BioTechniques
Schlagworte:Journal Article mRNA degradation nucleic acid preservation stool RNA stabilization stool based molecular diagnostics
LEADER 01000naa a22002652c 4500
001 NLM391386506
003 DE-627
005 20250819232352.0
007 cr uuu---uuuuu
008 250819s2025 xx |||||o 00| ||eng c
024 7 |a 10.1080/07366205.2025.2546762  |2 doi 
028 5 2 |a pubmed25n1534.xml 
035 |a (DE-627)NLM391386506 
035 |a (NLM)40824169 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Preywisch, Regina  |e verfasserin  |4 aut 
245 1 0 |a Stabilization of human RNA and DNA in stool samples at room temperature 
264 1 |c 2025 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Revised 18.08.2025 
500 |a published: Print-Electronic 
500 |a Citation Status Publisher 
520 |a This study examines the stability of human mRNA and DNA in stool samples for noninvasive gastrointestinal disease detection. While stool samples are valuable for diagnosing conditions like inflammatory disorders and colorectal cancer, mRNA instability poses significant challenges, risking false-negative results. To investigate this, 97 stool samples were treated with a specialized stabilizing solution and stored at room temperature, with analyses conducted on Day 1 and Day 15. The research aimed to improve storage protocols for enhanced reliability in mRNA diagnostics, aiding in personalized medicine and biomarker discovery. Results showed variability in total nucleic acid yields, increasing from Day 1 (mean 112 ng/µL) to Day 15 (mean 165 ng/µL), highlighting the benefits of improved homogenization and bacterial lysis. Human DNA remained stable over the 14-day period. For RNA stability, three mRNA markers were analyzed: Carcinoembryonic Antigen (CEACAM5), Prostaglandin-Endoperoxide Synthase 2 (PTGS2) and cortactin (CTTN). Both CEACAM5 (p=0.064) and PTGS2 (p=0.79) maintained stability, while CTTN showed a statistically significant but only modest reduction in expression (p < 0.0001). Overall, the stabilization buffer proved effectiveness in preserving nucleic acids and provided insights into mRNA marker stability over time 
650 4 |a Journal Article 
650 4 |a mRNA degradation 
650 4 |a nucleic acid preservation 
650 4 |a stool RNA stabilization 
650 4 |a stool based molecular diagnostics 
700 1 |a Løvlie, Roger  |e verfasserin  |4 aut 
700 1 |a Eidens, Moritz  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t BioTechniques  |d 1991  |g (2025) vom: 18. Aug., Seite 1-9  |w (DE-627)NLM012627046  |x 1940-9818  |7 nnas 
773 1 8 |g year:2025  |g day:18  |g month:08  |g pages:1-9 
856 4 0 |u http://dx.doi.org/10.1080/07366205.2025.2546762  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_21 
912 |a GBV_ILN_22 
912 |a GBV_ILN_24 
912 |a GBV_ILN_39 
912 |a GBV_ILN_40 
912 |a GBV_ILN_50 
912 |a GBV_ILN_60 
912 |a GBV_ILN_62 
912 |a GBV_ILN_65 
912 |a GBV_ILN_70 
912 |a GBV_ILN_99 
912 |a GBV_ILN_121 
912 |a GBV_ILN_130 
912 |a GBV_ILN_227 
912 |a GBV_ILN_350 
912 |a GBV_ILN_618 
912 |a GBV_ILN_640 
912 |a GBV_ILN_754 
912 |a GBV_ILN_2001 
912 |a GBV_ILN_2002 
912 |a GBV_ILN_2003 
912 |a GBV_ILN_2005 
912 |a GBV_ILN_2006 
912 |a GBV_ILN_2007 
912 |a GBV_ILN_2008 
912 |a GBV_ILN_2009 
912 |a GBV_ILN_2010 
912 |a GBV_ILN_2012 
912 |a GBV_ILN_2015 
912 |a GBV_ILN_2018 
912 |a GBV_ILN_2023 
912 |a GBV_ILN_2035 
912 |a GBV_ILN_2040 
912 |a GBV_ILN_2060 
912 |a GBV_ILN_2099 
912 |a GBV_ILN_2105 
912 |a GBV_ILN_2121 
912 |a GBV_ILN_2470 
951 |a AR 
952 |j 2025  |b 18  |c 08  |h 1-9